First large-scale analysis confirms that vulnerable patients remain at increased fatality to COVID-19 despite availability of vaccines
· Analysis includes data from UK Kidney Association (UKKA) on 9,388 COVID-19 cases among kidney patients in the UK of which 924 were fatal (Dec 2020 to March 2022) · The analyses underline the need for additional protection of dialysis and kidney transplant patients · Results published in peer-reviewed journal Transplantation · A significant unmet medical need persists to protect kidney patients, as well as other immunocompromised patients, as they may not mount proper antibody responses to COVID-19 vaccination Hellerup, Denmark, 2 January 2023 – UNION therapeutics A/S, a